News
Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...
Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
We recently published a list of Here’s What Fueled These 10 Firms’ Surge. In this article, we are going to take a look at ...
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
Thursday announced the appointment of Mo Elshenawy as the company’s new Chief Technology Officer. Shares up 1.9% premarket.
But Hims & Hers' shares fell in after-hours trading as second-quarter projections fell short of analysts' expectations. The ...
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Hims & Hers Health Inc. posted better-than-expected first-quarter revenue as the company pivots away from making copycat ...
Hims & Hers Health (NYSE:HIMS) plans to offer $450M aggregate principal amount of convertible senior notes due 2030 in a private offering. The notes will accrue interest payable semi-annually in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback